Clinical trial
Double-blinded Randomized Trial of Terbutaline to Shorten ICU Length of Stay in the Treatment of Status Asthmaticus in Children
NCT00124995 is registered in ClinicalTrials.gov with Connecticut Children's Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blinded Randomized Trial of Terbutaline to Shorten ICU Length of Stay in the Treatment of Status Asthmaticus in Children
- Lead sponsor
- Connecticut Children's Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- October 31, 2006
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.